A team of delegates from the Cell Biology Lab of School of Biotechnology, Amrita Vishwa Vidyapeetham, participated in the 3rd International Conference on Osteoarthritis, organized by the Indian Rheumatology Association, Karnataka Chapter, from August 3-4, 2019, at Bengaluru.
Every week Nature India hand-picks a selection of papers that might be of interest or relevance to the scientific community in the region. In this regard, researchers at the Amrita School of Biotechnology (ASBT), Amrita Vishwa Vidyapeetham, were thrilled to find that their work which was recently published in the USA based journal Bioorganic Chemistry (Kalyanvenkatraman S. et al, 66, 72-79, 2016) was the research pick of the week in Nature India.
Ms. Jayaleskhmi H., Vidhya Prakash and Suja Subhash represented Amrita School of Biotechnology and presented posters at the International Conference on New Horizons in Biotechnology 2015 (NHBT-2015) during November 22-25, 2015 in Thiruvananthapuram, Kerala.
Subhalakshmi K., Research Associate of Amrita Vishwa Vidyapeetham’s Cell Biology lab from the Amrita School of Biotechnology, participated and presented a poster at the International Conference on Cardiovascular Translational Research and the 13th Annual Conference of the International Society for Heart Research (ISHR) (Indian Section).
Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, joined hands with Wipro Technologies to build an end-to-end Diabetes Solution for Indian masses, funded by The Biotechnology Industry Research Assistance Council (BIRAC)- a Government of India Enterprise.
A Memorandum of Understanding (MOU) was signed by the Chancellor Master and Scholars of the University of Oxford acting for its Kennedy Institute of Rheumatology and by Dr. Bipin Nair, the Dean of Amrita School of Biotechnology, for Amrita Vishwa Vidyapeetham on January 12th, 2015.
The 2007 Nobel Laureate Dr. Rajendra Pachauri visited the School of Biotechnology as a part of his visit to the Amritapuri Campus of Amrita Vishwa Vidyapeetham, to inaugurate the Global. . .
